Boots Pharmaceuticals Sore Throat Relief Lemon Flavour 0.6 mg Lozenges

Šalis: Airija

kalba: anglų

Šaltinis: HPRA (Health Products Regulatory Authority)

Veiklioji medžiaga:

Amylmetacresol

Prieinama:

The Boots Company Plc

ATC kodas:

R02AA; R02AA20

INN (Tarptautinis Pavadinimas):

Amylmetacresol

Dozė:

0.6 milligram(s)

Vaisto forma:

Lozenge

Recepto tipas:

Product not subject to medical prescription

Gydymo sritis:

Antiseptics; various

Autorizacija statusas:

Marketed

Leidimo data:

2001-05-17

Prekės savybės

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Boots Pharmaceuticals Sore Throat Relief Lemon Flavour 0.6 mg Lozenges
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Amylmetacresol
0.6 mg per lozenge
Excipients:
Sucrose 1.50g
Glucose 1g
For full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Lozenge
Yellow, circular lozenges.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For the short-term symptomatic relief of sore throats.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults and Children over 12 years: One lozenge to be sucked when
required,
up to a maximum of 8 lozenges in 24
hours.
Children 5-12 years: One lozenge to be sucked when required up to a
maximum of 4 lozenges in 24 hours.
The maximum dose at any one time is one lozenge.
Children under 5 years: Not suitable.
4.3 CONTRAINDICATIONS
Hypersensitivity to any of the ingredients.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Keep all medicines out of the reach of children.
Do not exceed the stated dose.
If symptoms persist or worsen after 2-3 days see your doctor.
Information related specifically to the excipients in this formulation
(See Section 6.1).
Glucose: Each lozenge contains 1g glucose. This should be taken into
account by patients with diabetes mellitus.
Patients with rare glucose-galactose malabsorption should not take
this medicine.
Sucrose: Each lozenge contains 1.5g sucrose. This should be taken into
account by patients with diabetes mellitus.
Patients with rare hereditary problems of fructose intolerance,
glucose-galactose malabsorption or sucrose-isomaltase
insufficiency should not take this medicine.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___